View
225
Download
5
Category
Tags:
Preview:
DESCRIPTION
Â
Citation preview
Incorporated by Royal Charter Patron - Her Majesty The Queen
President Prof Andrew Jones BSc MSc FIPEM CSci FBIR
Chief Executive Ms Jacqueline Fowler BA, MInstF(Cert)
The British Institute of Radiology 48-50 St John Street London EC2M 4DG
T : +44(0)20 3668 2226 E : admin@bir.org.uk
www.bir.org.uk
Registered Charity No. 215869 VAT Registration No. GB 233 7553 63
Contrast study day
Meeting organised by the North Branch of
The British Institute of Radiology
Friday 24 January 2014
Liverpool Medical Institute
09:00 Registration, tea and coffee
Chair: Dr Elspeth Whitby, Senior Lecturer/Honorary Consultant,
University of Sheffield
09:20 Welcome
09:30 General applications for CT
Dr Matthew Bull, Consultant Radiologist,
Sheffield Teaching Hospitals NHS Trust
10:00 General applications for MR
Mr Kieran Murphy, Superintendent Radiographer MRI,
The Liverpool Heart & Chest Hospital
10:30 Dynamics of blood flow within the body
Dr Douglas Turner, Consultant Vascular Radiologist,
Sheffield Teaching Hospitals NHS Trust
11:00 MR contrast in children
Dr Gurdeep Mann, Consultant Radiologist,
Alder Hey Children’s Hospital
11:20 Tea and coffee
11:40 MR contrast agents and acquisition techniques
Professor Andrew Jones, Consultant Clinical Scientist,
The Christie NHS Foundation Trust
12:00 Contrast and CT colonography
Dr Milan Sapundzieski, Consultant Radiologist,
Pennine Acute Hospitals NHS Trust
12:30 Small bowel imaging
Dr Hannah Lambie, Consultant Radiologist,
St James’s University Hospital
13:00 Questions and discussion
13:10 Lunch
14:00 CT angiography
Dr Douglas Turner, Consultant Vascular Radiologist,
Sheffield Teaching Hospitals NHS Trust
14:30 MR angiography
Dr Douglas Turner, Consultant Vascular Radiologist,
Sheffield Teaching Hospitals NHS Trust
15:00 Safety aspects of contrast media (CT and MR)
Professor Andrew Jones, The Christie NHS Foundation Trust
Dr Matthew Bull, Consultant Radiologist,
Sheffield Teaching Hospitals NHS Trust
15:30 Tea and coffee
15:50 CT and MR of the liver
Dr Tony Blakeborough, Consultant Radiologist,
Sheffield Teaching Hospitals NHS Trust
16:20 Future directions of the BIR and the implications for
education
Professor Andrew Jones, Consultant Clinical Scientist,
The Christie NHS Foundation Trust
16:40 Questions and discussion
17:00 Close of meeting
CPD: 6 credits
Please complete the meeting evaluation survey online at:
https://www.surveymonkey.com/s/Contrast_day2
We will email your CPD certificate upon collation of your feedback.
We are most grateful to
For supporting this conference
Bayer HealthCare has provided sponsorship for the cost of the exhibition
stand only at this meeting.
Speaker profiles and abstracts (where supplied)
Biography
Dr Matthew Bull, Consultant Radiologist, Sheffield Teaching Hospitals NHS Trust
Matthew Bull is a Consultant Radiologist, Honorary Senior Lecturer and Clinical
Director in Sheffield Teaching Hospitals. His first exposure to CT was a medical
student accompanying an ill patient across the Pennines from Sheffield to
Manchester for a body scan in 1979 (in a list of only 4 patients the whole day). He
trained in Sheffield and New York. He has been a consultant since 1990 specialising
in chest and endocrine imaging and has been involved in CT all through his career.
Abstract
General applications for CT
The basic concept of contrast in imaging especially CT will be discussed
demonstrating methods of improving contrast. The various types of added contrast
media and limitations will be discussed. Several specific protocols including trauma
scanning will be shown. The benefits of contrast, nephrotoxicity and other potential
hazards and future trends will also be presented.
Safety aspects of contrast media (CT and MR)
The brief talk will cover
1. Treatment of contrast reactions.
2. Management of contrast in renal impairment
3. Management of patients on metformin receiving contrast.
Biography
Dr Gurdeep Mann, Consultant Radiologist, Alder Hey Children’s Hospital
Gurdeep is a paediatric radiologist with a specialist interest in body imaging. He
qualified from the University of Birmingham and after obtaining the MRCP (UK)
undertook general radiology training in Leicester and paediatric cardiac MR at Great
Ormond Street. He subsequently completed a paediatric radiology fellowship at
British Columbia Children’s Hospital, Vancouver, Canada. His main areas of interest
are cardiac cross-sectional imaging, MR imaging of inflammatory bowel disease,
paediatric gynaecological disease and prenatal MRI.
Abstract
MR contrast in children
Gadolinium based contrast agents (GBCA) are widely used in paediatric practice with
a relatively low risk of side-effects. The indications and contraindications for GBCA
are broadly similar to those in adults. Off-label use of GBCA in children is common
practice.
Where possible children should be ‘imaged gently’ and the indiscriminate use of
GBCA is to be avoided. Although there is no proven clinical risk, ideally GBCA should
not be administered to children aged less than one year and in particular newborns
and the unborn child as they have physiological ‘transitional nephrology’. Strategies
to avoid gadolinium use include phase contrast and time of flight angiography, non
contrast MR coupled with Doppler ultrasound.
Objectives:
Discuss the licensing, safety profile and contraindications for GBCA in children.
Discuss the main indications of GBCA using case studies.
Discuss strategies to avoid unnecessary GBCA administration in children.
Biography
Professor Andrew Jones, Consultant Clinical Scientist,
The Christie NHS Foundation Trust
Andrew is a Consultant Clinical Scientist within Christie Medical Physics and
Engineering at The Christie, Manchester and is Group Leader for Non-ionising
Imaging. The groups MR section provides scientific support to MRI users across the
North West region. He is a frequent lecturer covering a variety of subjects within
clinical MRI. Andrew is currently President of the BIR.
Abstract
MR contrast agents and acquisition techniques
An understanding of the nature and action of different MR contrast agents
An awareness of the differing agents available in the market along with their
applications and special characteristics
An overview of the nature of MR data capture and implications for the
resulting image appearances
A basic understanding of spatial frequency properties of k-space and the
different filling regimens
An appreciation of the use of different methods of k-space filling and their
advantages for MR angiography techniques
A general understanding of the basic physics that underpins contrast
enhanced MR angiography
An understanding of bolus timing and data acquisition strategies used in MR
angiography
Biography
Dr Milan Sapundzieski, Consultant Radiologist, Pennine Acute Hospitals NHS
Trust
Dr Milan Sapundzieski is a Consultant Radiologist from The Pennine Acute Hospitals
NHS Trust, Manchester. Besides general radiology, his special interest is
gastrointestinal and abdominal radiology and paediatric radiology. Sub special
interest is imaging of the large and small bowel. Milan is QA lead for radiology for
the North West of England, Bowel Cancer Screening Program. He also teaches at the
University of Salford, School of Radiography on the topics of gastrointestinal
radiology.
Abstract
Contrast and CT colonography
CTC took over as a primary imaging for suspected colonic pathology, especially
polyps and cancer. Sensitivity for large polyps and cancers is very high, where the
sensitivity for flat and small polyps, less than 6mm, is much smaller. It is not
indicated in IBD due to false positive findings.
Besides symptomatic patients, CTC is the only approved imaging modality for Bowel
Cancer Screening Patients, as alternative for incomplete or contraindicated
colonoscopy.
CTC involves specially trained radiographers, to perform and specially trained
radiologist to report the investigation to high standards.
Learning objectives:
What are technical requirements for successful CTC
How to do bowel preparation: standard , limited or none regime
Hypotonic medication and better patient comfort-iv Buscopan
How to do faecal tagging-oral contrast
How to do bowel distension-automatic CO2 insufflations vs. room air
insufflations
When to use iv contrast
What is standard report for CTC
References:
1. GUIDELINES FOR THE USE OF IMAGING IN THE NHS BOWEL CANCER SCREENING
PROGRAMME -Second Edition; NHSBCSP Publication No 5 ,09 November 2012
2. The second ESGAR consensus statement on CT colonography, European Radiology,
Springer, September 2012 (published on line)
Biography
Dr Hannah Lambie, Consultant Radiologist, St James’s University Hospital
Hannah Lambie trained as a radiologist in Leeds/W Yorkshire and is a Consultant
Radiologist specialising in gastro-intestinal radiology at St James’s University Hospital,
Leeds.
Abstract
Small bowel imaging
Educational Aims:
To explore the different methods to assess the small bowel, when to use
them and the contrast media used in imaging the small bowel
Talk outline:
The different methods to assess the small bowel including endoscopic and
radiological methods will be discussed. The pros and cons of each method and their
relative uses will be reviewed. Particular reference will be made to the contrast media
used to image the small bowel.
Learning outcomes:
Describe the methods used to assess the small bowel
Understand the indications for imaging the small bowel and when to use
the different imaging techniques
Know which contrast media are used and the rationale for using then
Biography
Dr Doug Turner, Consultant Vascular Radiologist,
Sheffield Teaching Hospitals NHS Trust
I work as a Consultant Vascular Radiologist at the Sheffield Vascular Institute.
I undertook a vascular radiology fellowship at the same institution, following general
radiology training on the Cambridge scheme.
My job comprises all aspects of vascular disease diagnosis and intervention outside
the coronary and intracranial circulations.
Abstract
CT angiography
Computed tomography angiography (CTA) is an important tool in the diagnosis of
vascular disease. Technological developments in scanner design in the last 20 years,
along with huge advances in computational power, have allowed greatly improved
spatial and temporal resolution imaging to be manipulated in powerful post-
processing algorithms; acquired isotropic volumetric data can be reformatted in any
plane, and luminal centre-line techniques for example, allow accurate stenosis
assessment and endovascular device sizing.
This presentation hopes to highlight the current role of CT angiography in the
diagnosis of vascular conditions, and to do this, we will review the technological
advances allowing effective CT angiographic imaging, touch upon the variables
contributing to successful image acquisition, and highlight some of the applications
of the technique. I will allude to some practical points regarding patient preparation
and scanning protocols, as well as avoiding pitfalls in image interpretation.
Abstract
Professor Andrew Jones, Christie Medical Physics and Engineering
The Christie NHS Foundation Trust
Dr Matthew Bull, Sheffield Teaching Hospitals NHS Trust
Safety aspects of MR contrast agents (CT and MR)
Learning objectives:
An appreciation of the general safety profile of gadolinium based MR contrast
agents
An awareness of differences between various types of MR contrast agents in
terms of their basic chemistry and excretion paths in-vivo
An understanding of the risks posed by nephrogenic systemic fibrosis (NSF)
and the relationship with gadolinium contrast agents
An understanding of the differing nature of various MR contrast products and
the associated risk factors for NSF
A knowledge of the licence implications around NSF for high risk agents
An awareness of the most up to date guidance on the safe use of gadolinium
contrast agents and their implications for clinical practice
Dr Tony Blakeborough, Consultant Radiologist,
Sheffield Teaching Hospitals NHS Trust
Trained in Leeds, where he did a fellowship in Liver MRI
Been a consultant in Sheffield since 1997, specialising in GI radiology, especially liver
MRI.
Abstract
CT and MR of the liver
Educational objectives:
To understand the dual blood supply of the liver and its impact on
enhancement of both normal liver and pathology.
To illustrate the differences between imaging the liver with CT and MRI, with
typical examples of focal lesions.
To describe the advantages of liver specific contrast agents for liver MRI.
Our platinum sponsors
GE Healthcare provides transformational medical technologies and services to meet
the demand for increased access, enhanced quality and more affordable healthcare
around the world. GE (NYSE: GE) works on things that matter - great people and
technologies taking on tough challenges. From medical imaging, software & IT,
patient monitoring and diagnostics to drug discovery, biopharmaceutical
manufacturing technologies and performance improvement solutions, GE Healthcare
helps medical professionals deliver great healthcare to their patients.
Philips is a diversified health and well-being company and a world leader in
healthcare, lifestyle and lighting. Our vision is to make the world healthier and more
sustainable through meaningful innovation.
We develop innovative healthcare solutions across the continuum of care, in
partnership with clinicians and our customers to improve patient outcomes, provide
better value, and expand access to care.
As part of this mission we are committed to fuelling a revolution in imaging
solutions, designed to deliver greater collaboration and integration, increased patient
focus, and improved economic value. We provide advanced imaging technologies
you can count on to make confident and informed clinical decisions, while providing
more efficient, more personalised care for patients.
The Siemens Healthcare sector is one of the world’s largest suppliers to the
healthcare industry and a trendsetter in medical imaging, laboratory diagnostics,
medical information technology and hearing aids. Siemens offers its customers
products and solutions for the entire range of patient care from a single source –
from prevention and early detection to diagnosis, and on to treatment and aftercare.
By optimising clinical workflows for the most
common diseases, Siemens also makes healthcare faster, better and more cost-
effective. For further information please visit: /www.siemens.co.uk/healthcare
FORTHCOMING EVENTS
Radiology errors
31 January 2014
London
Scottish Branch meeting: Recent advances in diagnostic imaging
14 February 2014
Glasgow
3rd Annual SPECT/CT symposium:
Current status and future directions of SPECT/CT imaging
24 February 2014
London
Multi-parametric imaging of prostate cancer -
can it facilitate a paradigm shift in management?
28 February 2014
London
Biological optimisation of radiotherapy
13 March 2014
London
Paediatric body MRI course
1 April 2014
London
Management and radiology - a guide to current and future management issues in
radiology
2 May 2014
London
Radiotherapy - meeting the current and future workforce challenges for patient
care in a changing context
19 May 2014
London
Molecular radiotherapy dosimetry
4 June 2014
Oxford
VISIT: WWW.BIR.ORG.UK FOR MORE INFORMATION AND TO REGISTER!
NOTES
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
NOTES
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
NOTES
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
NOTES
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
Recommended